Note: Ingredients listed on restricted chemical lists
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
1 - 3
EC/CAS
201-069-1/77-92-9
Name of the chemical
Citric acid
Concentration
0.1 - 1
EC/CAS
911-418-6/55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
0.001 - 0.01
General Information
Version
6.1
Revision date
2025-09-03
Product name
MIDA IDEAL PLUS
1.2.1 Relevant identified uses
Professional use
Manufacturer Name
CHRISTEYNS s.r.o
Emergency telephone
+353 1 809 2566, +353 1 809 2166, 0344 892 0111
Icons in SDS
Company Information
company name
CHRISTEYNS s.r.o
e-mail address of the competent person responsible for the Safety Data Sheet
legislativa@christeyns.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H318
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
No additional information available
Hazard pictograms
GHS05
Signal word
Danger
Contains
Sodium dodecylbenzenesulfonate; tetrasodium ethylene diamine tetraacetate; Laurylethoxy(3EO)sulphate, sodium salt
Hazard statements
H315 - Causes skin irritation. H318 - Causes serious eye damage.
Precautionary statements
P280 - Wear eye protection, protective gloves. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 - Immediately call a POISON CENTER/doctor. P501 - Dispose of contents and container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
Supplemental label elements
EUH208 - Contains METHYLCHLOROISOTHIAZOLINONE (AND) METHYLISOTHIAZOLINONE. May produce an allergic reaction.
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 1 H318 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available
